Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Fradet

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
The American Journal of Pathology|July 8, 1999
Deletions of the INK4A gene in superficial bladder tumors. Association with recurrenceI Orlow, H LaRue, I Osman, et al.
The Prostate|April 1, 1996
Androgen receptor modulation in benign human prostatic tissue and prostatic adenocarcinoma during neoadjuvant endocrine combination therapyT H Van der Kwast, B Têtu, Y Fradet, et al.
The Urologic Clinics of North America|February 1, 1991
Total androgen ablation: Canadian experienceG Béland, M Elhilali, Y Fradet, et al.
Cancer Surveys|January 1, 1995
Downstaging by combination therapy with flutamide and an LHRH agonist before radical prostatectomyF Labrie, L Cusan, J L Gomez, et al.
Cancer|September 1, 1990
A controlled trial of castration with and without nilutamide in metastatic prostatic carcinomaG Béland, M Elhilali, Y Fradet, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 1, 1996
Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year StudyJ C Nickel, Y Fradet, R C Boake, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1993
Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesisJ Y Rao, G P Hemstreet, R E Hurst, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 1, 1993
Downstaging of localized prostate cancer by neoadjuvant therapy with flutamide and lupron: the first controlled and randomized trialF Labrie, A Dupont, L Cusan, et al.
Urology|March 1, 1997
Neoadjuvant hormonal therapy: the Canadian experienceF Labrie, L Cusan, J L Gomez, et al.
The American Journal of Surgical Pathology|January 1, 1996
Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. A randomized studyL Vailancourt, B Ttu, Y Fradet, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
The American Journal of Pathology|July 8, 1999
Deletions of the INK4A gene in superficial bladder tumors. Association with recurrenceI Orlow, H LaRue, I Osman, et al.
The Prostate|April 1, 1996
Androgen receptor modulation in benign human prostatic tissue and prostatic adenocarcinoma during neoadjuvant endocrine combination therapyT H Van der Kwast, B Têtu, Y Fradet, et al.
The Urologic Clinics of North America|February 1, 1991
Total androgen ablation: Canadian experienceG Béland, M Elhilali, Y Fradet, et al.
Cancer Surveys|January 1, 1995
Downstaging by combination therapy with flutamide and an LHRH agonist before radical prostatectomyF Labrie, L Cusan, J L Gomez, et al.
Cancer|September 1, 1990
A controlled trial of castration with and without nilutamide in metastatic prostatic carcinomaG Béland, M Elhilali, Y Fradet, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 1, 1996
Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year StudyJ C Nickel, Y Fradet, R C Boake, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1993
Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesisJ Y Rao, G P Hemstreet, R E Hurst, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 1, 1993
Downstaging of localized prostate cancer by neoadjuvant therapy with flutamide and lupron: the first controlled and randomized trialF Labrie, A Dupont, L Cusan, et al.
Urology|March 1, 1997
Neoadjuvant hormonal therapy: the Canadian experienceF Labrie, L Cusan, J L Gomez, et al.
The American Journal of Surgical Pathology|January 1, 1996
Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. A randomized studyL Vailancourt, B Ttu, Y Fradet, et al.
Pageof 11